​

Ardent Health (ARDT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ARDT Stock Forecast

Ardent Health (ARDT) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $13.33, with a high of $14.00 and a low of $13.00. This represents a 15.01% increase from the last price of $11.59.

$11 $12 $13 $14 $15 $16 $17 $18 $19 High: $14 Avg: $13.33 Low: $13 Last Closed Price: $11.59

ARDT Stock Rating

Ardent Health stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (66.67%), 3 Hold (25.00%), 1 Sell (8.33%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 1 3 8 Strong Sell Sell Hold Buy Strong Buy

ARDT Price Target Upside V Benchmarks

TypeNameUpside
StockArdent Health15.01%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks14.47%

Price Target Trends

1M3M12M
# Anlaysts2212
Avg Price Target$13.50$13.50$14.33
Last Closing Price$11.59$11.59$11.59
Upside/Downside16.48%16.48%23.64%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Aug, 26164-112
Jul, 26164-112
Jun, 26154-111
May, 26164-112
Apr, 26174-113
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 06, 2026Goldman Sachs$13.00$11.2515.56%12.17%
Aug 06, 2026Jason CassorlaGuggenheim$14.00$11.1625.45%20.79%
Mar 09, 2026Ben HendrixRBC Capital$13.00$9.1741.77%12.17%
Dec 18, 2025UBS$14.00$8.9456.60%20.79%
Dec 18, 2025Ann HynesMizuho Securities$12.00$8.9434.23%3.54%
Nov 18, 2025Mizuho Securities$13.00$8.7049.43%12.17%
Nov 14, 2025Whit MayoLeerink Partners$16.00$9.0177.58%38.05%
Nov 14, 2025Truist Financial$13.00$8.9245.74%12.17%
Nov 14, 2025Ben HendrixRBC Capital$16.00$8.9778.37%38.05%
Nov 14, 2025Morgan Stanley$12.00$9.3029.03%3.54%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 06, 2026Goldman SachsNeutralNeutralhold
Aug 06, 2026GuggenheimBuyBuyhold
Mar 09, 2026RBC CapitalOutperformOutperformhold
Nov 17, 2025KeyBancOverweightSector Weightdowngrade
Nov 14, 2025RBC CapitalOutperformOutperformhold
Oct 14, 2025Goldman SachsNeutralinitialise
Sep 10, 2025UBSBuyinitialise
Mar 04, 2025RBC CapitalOutperformOutperformhold
Nov 06, 2024Bank of America SecuritiesNeutraldowngrade
Oct 10, 2024KeyBancOverweightinitialise

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$0.35$1.59$0.96--
Avg Forecast$0.18$1.22$1.99$2.19$2.38
High Forecast$0.18$1.31$2.14$2.46$2.51
Low Forecast$0.18$1.06$1.84$2.05$2.25
Surprise %94.44%30.33%-51.76%--

Revenue Forecast

$5B $6B $6B $7B $7B $8B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$5.41B$5.97B$6.32B--
Avg Forecast$5.63B$5.85B$6.32B$6.68B$7.09B
High Forecast$5.66B$5.86B$6.36B$6.74B$7.15B
Low Forecast$5.59B$5.84B$6.29B$6.60B$7.00B
Surprise %-3.98%1.98%0.07%--

Net Income Forecast

$0 $80M $160M $240M $320M $400M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$50.29M$210.34M$135.81M--
Avg Forecast$25.47M$169.77M$277.05M$314.47M$340.30M
High Forecast$25.68M$187.67M$306.58M$352.43M$359.59M
Low Forecast$25.26M$151.86M$263.60M$293.69M$322.34M
Surprise %97.47%23.90%-50.98%--

ARDT Forecast FAQ

Is Ardent Health stock a buy?

Ardent Health stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 3 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Ardent Health is a favorable investment for most analysts.

What is Ardent Health's price target?

Ardent Health's price target, set by 12 Wall Street analysts, averages $13.33 over the next 12 months. The price target range spans from $13 at the low end to $14 at the high end, suggesting a potential 15.01% change from the previous closing price of $11.59.

How does Ardent Health stock forecast compare to its benchmarks?

Ardent Health's stock forecast shows a 15.01% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical care facilities stocks industry (14.47%).

What is the breakdown of analyst ratings for Ardent Health over the past three months?

  • August 2026: 8.33% Strong Buy, 50.00% Buy, 33.33% Hold, 0% Sell, 8.33% Strong Sell.
  • July 2026: 8.33% Strong Buy, 50.00% Buy, 33.33% Hold, 0% Sell, 8.33% Strong Sell.
  • June 2026: 9.09% Strong Buy, 45.45% Buy, 36.36% Hold, 0% Sell, 9.09% Strong Sell.

What is Ardent Health’s EPS forecast?

Ardent Health's average annual EPS forecast for its fiscal year ending in December 2026 is $2.19, marking a 128.12% increase from the reported $0.96 in 2025. Estimates for the following years are.

What is Ardent Health’s revenue forecast?

Ardent Health's average annual revenue forecast for its fiscal year ending in December 2026 is $6.68B, reflecting a 5.66% increase from the reported $6.32B in 2025. The forecast for.

What is Ardent Health’s net income forecast?

Ardent Health's net income forecast for the fiscal year ending in December 2026 stands at $314.47M, representing an 131.55% increase from the reported $135.81M in 2025. Projections indicate .